The following is an excerpt from a recent scientific publication:“In contrast to the traditional mechanism of drug action that relies on the reversible, noncovalent interaction of a ligand with its biological target, a targeted covalent inhibitor (TCI) is designed such that the initial, reversible association is followed by the formation of a covalent bond between an electrophile on the ligand and a nucleophilic center in the protein. Although this approach offers a variety of potential benefits (high potency and extended duration of action), concerns over the possible toxicological consequences of protein haptenization have hindered the development of the TCI concept. Recently, approaches to mitigate the risk of serious adverse reactions to this new class of agent have emerged, thus stimulating interest in the field and leading to authorization of the first cadre of TCIs to be marketed. The covalent inhibitor approach is rapidly gaining acceptance as a valuable tool in drug discovery, and is poised to make a major impact on the design of enzyme inhibitors and receptor modulators.” Based on this excerpt, what is the defining two‑stage mechanism of targeted covalent inhibitors (TCIs)?

Which statement about oxygen release from hemoglobin versus myoglobin is most accurate?

Which of the following amino acids is the least likely to be found in the interior of a globular protein?

Which change is expected for a competitive inhibitor in classic Michaelis–Menten behavior?

Why is acetone less reactive toward nucleophilic attack than formaldehyde?

What type of interaction is primarily responsible for the aggregation of nonpolar molecules in water?

Which amino acid has a side chain that, due to its small size and lack of chirality, introduces conformational flexibility in protein loops?

Which amino acid’s side chain can form a zwitterionic resonance-stabilized interaction in the active site of some enzymes?

The following is an excerpt from a recent scientific publication:“Specific noncovalent interactions that are indicative of attractive, directional intermolecular forces have always been of key interest to medicinal chemists in their search for the ‘glue’ that holds drugs and their targets together. … we survey … three kinds of strong, specific, direct, enthalpy‑driven intermolecular forces, including hydrogen bond, halogen bond and salt bridge, involved in the formation of protein‑ligand complex architecture … biological functions … in conferring affinity and specificity for ligand recognition by host protein.” Which interactions are highlighted here as enthalpy‑driven contributors to affinity and specificity in drug design?

Which situation below would most weaken a hydrogen bond between two molecules?